Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Aug 31;11(9):1160.
doi: 10.3390/brainsci11091160.

Objective and Subjective Prevalence of Obstructive Sleep Apnoea/Hypopnoea Syndrome in UK Adults with Down Syndrome: A Strong Marker for Diurnal Behavioural Disturbances

Elizabeth A Hill  1 , Linda J Williams  2 , Sally-Ann Cooper  3 , Renata L Riha  1   4
Affiliations

Objective and Subjective Prevalence of Obstructive Sleep Apnoea/Hypopnoea Syndrome in UK Adults with Down Syndrome: A Strong Marker for Diurnal Behavioural Disturbances

Elizabeth A Hill et al. Brain Sci. .

Abstract

Prior to this study, the prevalence of obstructive sleep apnoea/hypopnoea syndrome (OSAHS) in adults with Down syndrome was unknown. We hypothesized that unrecognised OSAHS could have an additional deleterious impact on mood and behavioural disturbances in this group of people.

Aims: To assess the prevalence of OSAHS in adults with Down syndrome in the United Kingdom, subjectively and objectively, and ascertain its association with diurnal behavioural disturbances.

Method: Cross-sectional questionnaire study with home sleep apnoea testing (HSAT) during 2011-2015 across the four nations of the United Kingdom. Participants were adults aged ≥16 years with Down syndrome. Main outcome measures were: self- or caregiver-completed questionnaire data, including the Pictorial Epworth Sleepiness Scale (pESS), selected domains of the Developmental Behavioural Checklist for Adults (DBC-A), anthropometric measures, and symptoms of OSAHS. Objective prevalence was undertaken in a sample of responders using HSAT.

Results: Responses were received from 1321/5270 participants (25%), with 1105 valid responses (21%). Eighty-one participants (7%) reported a prior diagnosis of OSA, of whom 38 were receiving therapy. Using validated algorithms, a diagnosis of OSAHS was probable in 366 participants (35%), who were younger, with higher BMI and higher mean total pESS (p < 0.0001). A total of 23% of participants had a pESS > 10. OSAHS was a strong marker for behavioural disturbances on the DBC-A depression, disruption and anti-social subscales (p < 0.001). Of 149 individuals who underwent HSAT, 42% were diagnosed with OSAHS.

Conclusions: Untreated OSAHS in Down syndrome is common and associated with behavioural and mood disturbances. Improving awareness of OSAHS amongst adults with Down syndrome, their families and healthcare professionals is essential.

Keywords: down syndrome; excessive daytime sleepiness; home sleep apnoea testing; obstructive sleep apnoea; prevalence; sleep-related breathing disorders; trisomy 21.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Summary of questionnaires distributed to adults with Down syndrome residing within the UK, returned to the investigators and included in the final analysis.
Figure 2
Figure 2
Summary of questionnaire responders entering the objective prevalence study.
See this image and copyright information in PMC

References

    1. Loane M., Morris J., Addor M.-C., Arriola L., Budd J., Doray B., Garne E., Gatt M., Haeusler M., Khoshnood B., et al. Twenty-year trends in the prevalence of down syndrome and other trisomies in Europe: Impact of Maternal Age and Prenatal Screening. Eur. J. Hum. Genet. 2013;21:27–33. doi: 10.1038/ejhg.2012.94. - DOI - PMC - PubMed
    1. Wu J., Morris J.K. The population prevalence of Down’s Syndrome in England and Wales in 2011. Eur. J. Hum. Genet. 2013;21:1016–1019. doi: 10.1038/ejhg.2012.294. - DOI - PMC - PubMed
    1. Antonarakis S.E., Skotko B.G., Rafii M.S., Strydom A., Pape S.E., Bianchi D.W., Sherman S.L., Reeves R.H. Down Syndrome. Nat. Rev. Dis. Prim. 2020;6:1–20. doi: 10.1038/s41572-019-0143-7. - DOI - PMC - PubMed
    1. Jennum P., Riha R.L. Epidemiology of Sleep Apnoea-Hypopnoea Syndrome and Sleep-Disordered Breathing. Eur. Respir. J. 2009;33:907–914. doi: 10.1183/09031936.00180108. - DOI - PubMed
    1. Fernandez F., Edgin J.O. Poor sleep as a precursor to cognitive decline in Down Syndrome: A Hypothesis. J. Alzheimer Dis. Parkinsonism. 2013;3:124. - PMC - PubMed

LinkOut - more resources